1. Market Research
  2. > Healthcare Market Trends
EUROPE ANTI-RHEUMATICS MARKET FORECAST 2020-2028

EUROPE ANTI-RHEUMATICS MARKET FORECAST 2020-2028

  • April 2020
  • 115 pages
  • ID: 5880963
  • Format: PDF
  • Inkwood Research

Summary

Table of Contents

KEY FINDINGS
The Europe anti-rheumatics market is predicted to reach a CAGR of 2.10% over the forecast period of 2020-2028. A huge patient base of rheumatoid arthritis, owing to a large geriatric population, is one of the crucial factors favoring the market growth in the region.

MARKET INSIGHTS
The Europe anti-rheumatics market is researched further by segmenting the region into countries such as France, Russia, the UK, Poland, Germany, Belgium, Italy, and the rest of Europe that comprises of Greece, Austria, Netherland, Switzerland, Spain, Ireland, among others. In Russia, the prevalence of RA is estimated at 0.61% and has remained stable over the years. RA has been associated with many humanistic outcomes in spite of its low prevalence. Rheumatic disease is the second most common pathology after cardiovascular disorders, with 10% of the population being affected by RD. The most common RDs are osteoarthritis, rheumatoid arthritis, gout, and low back pain. The major factors responsible for the rising prevalence of RDs are hypertension, obesity, diabetes mellitus, and others. In countries like Belgium, the RA deaths accounted for 0.07% of the total deaths. Currently, around 80,000 to 100,000 people have this medical condition in Belgium. Since there is no known cure for RA, physicians focus on suppressing the disease. Therapies have improved in recent years, and intensive treatment in the early stages of RA can prevent joint damage and improve quality of life. The rapid improvement in therapy is driving the market.
In Poland, the most widely used DMARDs is methotrexate, which, in accordance with EULAR recommendations, is administered in RA treatment.Moreover, the program for the treatment of GPA and MPA was introduced, thereby promoting the market growth.

The prevalence of RA, together with the increasing healthcare facilities, are propelling the market growth in the rest of Europe.

COMPETITIVE INSIGHTS
F. Hoffmann-La Roche Ltd, Abbott Laboratories, Novartis International AG, UCB, Becton, Dickinson, and Company, etc. are some of the renowned companies functioning in the market.

Companies mentioned
1. ABBOTT LABORATORIES
2. ABBVIE INC
3. AMGEN INC
4. BECTON, DICKINSON & COMPANY (BD)
5. BIO-RAD LABORATORIES INC
6. BRISTOL-MYERS SQUIBB COMPANY
7. ELI LILLY & COMPANY
8. LUPIN LIMITED
9. F. HOFFMANN-LA ROCHE
10. JOHNSON & JOHNSON
11. MERCK & CO INC
12. NOVARTIS AG
13. PERKINELMER
14. PFIZER INC
15. UCB

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Proton Therapy Market Size, Share, Global Forecast 2022-2027, Industry Trends, Impact of COVID-19, Opportunity Company Analysis

  • $ 3000
  • November 2021
  • 315 pages

Proton Therapy Market Size, Share, Global Forecast 2022-2027, Industry Trends, Impact of COVID-19, Opportunity Company Analysis Proton therapy is a type of radiation called proton beam radiation therapy ...

  • World
  • Healthcare
  • Pathology
  • Industry analysis
  • Cancer Mortality
  • Cancer Incidence

ref:plp2020

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on